Fintel reports that on May 13, 2026, BTIG initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Buy recommendation.
Analyst Price Forecast Suggests 149.53% Upside
As of April 28, 2026, the average one-year price target for BioAge Labs is $45.39/share. The forecasts range from a low of $9.09 to a high of $76.65. The average price target represents an increase of 149.53% from its latest reported closing price of $18.19 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for BioAge Labs is 3MM, a decrease of 71.52%. The projected annual non-GAAP EPS is -3.24.
What is the Fund Sentiment?
There are 127 funds or institutions reporting positions in BioAge Labs. This is an decrease of 28 owner(s) or 18.06% in the last quarter. Average portfolio weight of all funds dedicated to BIOA is 0.21%, an increase of 163.99%. Total shares owned by institutions increased in the last three months by 12.80% to 25,698K shares. 
The put/call ratio of BIOA is 0.34, indicating a bullish outlook.
What are Other Shareholders Doing?
AH Capital Management, L.L.C. holds 3,233K shares representing 7.27% ownership of the company. No change in the last quarter.
Sofinnova Investments holds 2,294K shares representing 5.16% ownership of the company. No change in the last quarter.
Cormorant Asset Management holds 2,041K shares representing 4.59% ownership of the company. In its prior filing, the firm reported owning 2,141K shares , representing a decrease of 4.90%. The firm increased its portfolio allocation in BIOA by 43.74% over the last quarter.
Octagon Capital Advisors holds 1,598K shares representing 3.59% ownership of the company.
Vanguard Capital Management holds 1,355K shares representing 3.05% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
